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bi-phasic and tri-phasic RP was associated with lower digi-
tal perfusion. In contrast, no associations between skin 
temperature and RP digital colour changes/phases were 
identified in FMS. Our findings suggest that symptoms of 
RP in FMS may have a different aetiology to those seen 
in primary RP. These findings have potential implications 
for both the classification of RP symptoms and the manage-
ment of RP symptoms in the context of FMS. Digital col-
our changes reported by patients might reflect the degree of 
digital microvascular compromise in primary RP.
Keywords Raynaud’s phenomenon · Fibromyalgia 
syndrome · Thermography · Objective · Self-report · 
Classification
Abbreviations
RP  Raynaud’s phenomenon
FMS  Fibromyalgia syndrome
NC  Nailfold capillaroscopy
TG  Thermal gradient
AVAs  Arteriovenous anastamoses
SSc  Systemic sclerosis
Introduction
Raynaud’s phenomenon (RP) describes intermittent exces-
sive vasoconstriction of digital vessels in response to cold 
exposure and emotional stress [1]. Attacks of RP are typi-
cally associated with digital cutaneous colour changes 
including a “white” phase (vasoconstriction), a “blue” 
phase (cyanosis) and a “red” phase (reactive hyperaemia) 
[1]. Due to its episodic nature, objective evidence of digi-
tal microvascular dysfunction is not typically evident on 
clinical assessment, which has led to reliance upon patient 
Abstract Symptoms of Raynaud’s phenomenon (RP) are 
common in fibromyalgia syndrome (FMS). We compared 
symptom characteristics and objective assessment of digi-
tal microvascular function using infrared thermography 
(and nailfold capillaroscopy where available) in patients 
with FMS (reporting RP symptoms) and primary RP. We 
retrospectively reviewed the outcome of microvascular 
imaging studies and RP symptom characteristics (cap-
tured using patient-completed questionnaire at the time of 
assessment) for patients with FMS (reporting RP symp-
toms) and patients with primary RP referred for thermo-
graphic assessment of RP symptoms over a 2-year period. 
Of 257 patients referred for thermographic assessment of 
RP symptoms between 2010 and 2012, we identified 85 
patients with primary RP and 43 patients with FMS. There 
were no differences in RP symptom characteristics between 
FMS and primary RP (p > 0.05 for all comparisons). In 
contrast, patients with FMS had higher baseline tempera-
ture of the digits (32.1 vs. 29.0 °C, p = 0.004), dorsum 
(31.9 vs. 30.2 °C, p = 0.005) and thermal gradient (tem-
perature of digits minus temperature of dorsum; +0.0 vs. 
−0.9 °C, p = 0.03) compared with primary RP. Significant 
differences between groups persisted following local cold 
challenge. In primary RP, patient reporting “blue” digits, 
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self-report. A history of increased sensitivity to cold and 
the presence of two digital colour changes are considered 
sufficient to make a “definite” diagnosis of RP [2]. Recent 
studies have reported a high frequency of RP symptoms 
(18.2–53.3 %) in patients with fibromyalgia syndrome 
(FMS) [3–6]. Structural and functional microvascular dis-
turbance has been reported in FMS compared with healthy 
controls [6–9]. To date, no studies have compared and con-
trasted RP symptom characteristics and outcome of micro-
vascular imaging studies in FMS (reporting RP symptoms) 
and primary RP. We retrospectively assessed RP symptom 
characteristics and microvascular imaging study findings 
(infrared thermography ± nailfold capillaroscopy [NC]) in 
patients with a clinician diagnosis of either FMS or primary 
RP referred for assessment of RP symptoms over a 2-year 
period.
Materials and methods
A retrospective review of patients referred for thermo-
graphic evaluation of RP symptoms at our unit between 
2010 and 2012 was undertaken. Local research and devel-
opment approval was obtained for the study (Ref RBB389). 
We received written confirmation from the National 
Research Ethics Service confirming that Research Eth-
ics Committee approval was not required for a retrospec-
tive review of data obtained under normal clinical practice 
[under UK-wide Governance Arrangements for Research 
Ethics Committees (GAfREC)].
Subjects
A retrospective case note review of patients referred for 
thermographic evaluation of RP symptoms was undertaken 
to determine diagnosis. A diagnosis of primary RP was 
based on a final clinician diagnosis of “primary RP”, but 
also required the absence of clinical features of an underly-
ing rheumatic disease or CTD and a negative ANA (immu-
nofluorescence on Hep-2 cells negative at >1:160 dilution). 
A diagnosis of FMS required was based on documentation 
of widespread pain and tenderness of at least 11 of the 18 
FMS trigger points using 1990 ACR criteria [11] and/or a 
final clinician diagnosis of FMS.
Patient questionnaire
All patients referred for thermographic assessment of RP 
symptoms complete a short questionnaire during 20-min 
acclimatization at 23 °C. The questionnaire captures clini-
cal characteristics of RP using criteria derived from the 
consensus view of the UK Scleroderma Study Group in 
an earlier validation study [2]. The questionnaire records 
whether fingers are sensitive to cold, whether they show 
digital colour changes (white, red, blue and purple), 
whether patients experience numbness or paraesthesia 
in response to cold and the presence of symptoms in the 
absence of cold exposure. The questionnaire also collects 
relevant information including smoking history, cardio-
vascular risk factors (diabetes mellitus, dyslipidaemia and 
hypertension) and vasodilator medication use to aid subse-
quent interpretation of microvascular imaging studies.
Thermal imaging protocol and analysis
All patients had undergone a cold stress test (CST) under 
the same standardized conditions. Following 20-min accli-
matization (at 23 ± 0.5 °C), thermographic images were 
taken of the dorsum of the hands (Thermovision Camera, 
FLIR systems, Danderyd, Sweden). Patients then sub-
merged their hands (in polythene gloves to avoid evapo-
rative cooling) to the level of the radio-carpal joint into a 
water bath cooled to 20 °C (±0.1 °C) for 60 s. A second 
thermal image of the dorsum of the hands was captured 
10 min following cold challenge. Images were processed 
using commercially available software (CTHERM, version 
2.3, University of Glamorgan). Regions of interest encom-
passing the 2nd–5th digits (distal to metacarpophalangeal 
joints) and dorsum of hand were prepared and the mean 
surface skin temperature within each region of interest 
recorded. The thermal gradient (TG) was calculated by sub-
tracting the mean temperature of the dorsum of the hands 
from the mean temperature of the digits. A mean thermal 
gradient of both hands was calculated at both baseline and 
following cold challenge. In healthy controls, the TG is 
typically positive (~+1 to 2 °C) as the digital temperature 
(~33 °C) is typically greater than the dorsum of the hand 
(~31 °C) at baseline assessment and following cold chal-
lenge due to the action of thermoregulatory arteriovenous 
anastomoses (AVAs) within glabrous regions of the finger-
tips. In Raynaud’s phenomenon, the TG is typically nega-
tive (−1 to 3 °C) due to a lower digital temperature (~26–
28 °C) in comparison with the dorsum of the hand (~31 °C) 
due to closure of thermoregulatory AVAs in resting state or 
in response to cold provocation. The TG (and related ther-
mographic parameters such as the distal dorsal difference) 
has been successfully applied to differentiate disease states 
in populations of healthy controls, primary RP and second-
ary RP.
Nailfold capillaroscopy protocol and analysis
NC (when requested at the discretion of the treating clini-
cians) was performed at the index, middle and ring fingers 
of each hand using a pillar-mounted 1.3 megapixel camera 
(PL-A742, PixeLINK) at a magnification of 200×. Images 
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were analysed using PixeLINK Capture OEM software. 
NC images of all digits were reviewed (without knowledge 
of diagnosis) by two blinded assessors (BV and MS), and 
patients were categorized as having either normal, mild 
non-specific abnormalities or scleroderma-pattern abnor-
malities using classification criteria proposed by Cutolo 
et al. [10]. Indeterminate cases were reviewed by a blinded 
third assessor (JP) and consensus reached.
Statistical analysis
Comparisons were made between the two patient groups 
for baseline demographics (age, smoking history, vasodila-
tor medication use and cardiovascular disease), RP symp-
tom characteristics, thermographic analysis at baseline and 
following CST (absolute skin temperature at digits, dorsum 
and thermal gradient) and NC changes (when available). 
Additional analyses were undertaken to evaluate potential 
associations between the type and number of digital colour 
changes reported by patients and the outcome of thermo-
graphic assessments. Categorical variables are reported as 
numbers and/or percentages and were compared using Chi-
square test. Quantitative variables are reported as medians 
(interquartile range), and differences were assessed using 
Mann–Whitney U test. All analyses were two-tailed, and a 
p value of ≤0.05 was considered statistically significant.
Results
Two hundred and fifty-seven patients underwent thermo-
graphic assessment of RP symptoms between 2010 and 
2012. The case note review identified 128 patients who ful-
filled our criteria for either primary RP (n = 85) or FMS 
(n = 43). NC had been undertaken in 66 patients (48 pri-
mary RP). There was a greater number of current smok-
ers in the FMS group (37.2 vs. 16.5 %, p = 0.009) but no 
other statistically significant differences between groups in 
terms of baseline demographics, conventional cardiovascu-
lar risk factors or vasodilator use (Table 1). No differences 
were identified between primary FMS and primary RP for 
either individual reported digital colour changes, the num-
ber of digital colour changes (i.e. mono-phasic, bi-phasic, 
etc.) or other symptom characteristics (Table 1). For each 
group, “white” was the most commonly reported digital 
colour change (~68 %) with similar proportions of patients 
(~30 %) reporting mono-phasic, bi-phasic and tri-phasic 
RP attacks.
In contrast, significantly lower skin temperature of the 
digits [29.0 (7.3) vs. 32.1 °C (7.3), p = 0.004], dorsum 
[30.2 (4.4) vs. 31.9 °C (4.3), p = 0.005] and thermal gra-
dient [−0.9 (3.1) vs. +0.0 °C (3.0), p = 0.03] was identi-
fied in primary RP compared with FMS. Following CST, 
patients with primary RP continued to have significantly 
lower skin temperature at the digits and dorsum of the 
hand, with a strong trend for a lower TG post-CST com-
pared with FMS (Table 1).
The majority of patients with both primary RP and FMS 
had normal NC (64.6 and 83.3 %, respectively). Subtle NC 
changes were found in primary RP more commonly than 
in FMS although this trend did not achieve statistical sig-
nificance (31.3 vs. 16.7 %, p = 0.24). Due to the blinded 
nature of our NC review, two patients with primary RP 
(4.1 %) were identified in this study as having “early” scle-
roderma NC changes. Both patients were ANA negative 
and did not have any clinical features of SSc (or alterna-
tive CTD). Repeat statistical analysis excluding these two 
subjects from the primary RP group did not influence the 
outcome of the study (data not reported). There were no 
significant differences in skin temperature of the digits, 
dorsum or thermal gradient in patients with primary RP 
with normal NC versus abnormal NC changes (p > 0.05 for 
all comparisons). In contrast, FMS patients with subtle NC 
changes compared with those with normal NC appearances 
appeared to have slightly lower skin temperature of the dig-
its (26.0 vs. 32.8 °C, p = 0.09) and a significantly lower 
thermal gradient (−2.4 vs. +0.5 °C, p = 0.006) although 
these findings must be considered with caution in the con-
text of a low number of patients with FMS and NC changes 
(n = 3).
We examined the possible relationship between indi-
viduals reported digital colour changes and thermographic 
assessment. Across the whole cohort, reporting “blue” digi-
tal colour changes was associated with a significantly lower 
baseline digital (27.8 vs. 31.7 °C, p = 0.005) and base-
line dorsal (29.7 vs. 31.4 °C, p = 0.007) skin temperature, 
along with a corresponding lower TG (−1.8 vs. −0.2 °C, 
p = 0.06). Significant associations were also identified 
in patients reporting “purple” colour changes (Table 2). 
When assessing the primary RP group in isolation, sig-
nificantly lower baseline skin temperature was identified 
in patients reporting “blue” digital colour changes for the 
digits (27.4 vs. 30.5 °C, p = 0.017) and dorsum (29.5 vs. 
31.1 °C, p = 0.023) of the hands (Table 2). Similar asso-
ciations between “blue” and “purple” reported digital col-
our changes and skin temperature (of the digits and dor-
sum) were identified following cold challenge (data not 
reported). In contrast, there was no association between 
reported digital colour changes and thermographic assess-
ment of the hands at baseline (or following cold challenge) 
in patients with FMS (Table 2).
Exploring the relationship between the number of colour 
changes in RP attacks and thermographic assessment iden-
tified some intriguing observations. Bi- and tri-phasic RP 
was associated with lower baseline digital and dorsum skin 
temperature compared with mono-phasic RP (Table 3). 
 Rheumatol Int
1 3
Digital and dorsal skin temperatures remained significantly 
lower in tri-phasic compared with mono-phasic RP fol-
lowing cold challenge in primary RP. In contrast, bi- and 
tri-phasic RP was associated with higher baseline skin tem-
perature compared with mono-phasic RP in FMS (Table 3). 
No significant associations between the number of colour 
changes reported and thermographic assessment following 
cold challenge were identified in FMS.
Discussion
The present study has identified similar patient-reported 
characteristics of RP in patients with FMS (reporting RP 
symptoms) compared with primary RP, despite little objec-
tive evidence of digital microvascular compromise in FMS 
on objective imaging. Our findings would not support 
an association between FMS and digital microvascular 
Table 1  Baseline 
characteristics, questionnaire 
results, thermographic 
assessment and nailfold 
capillaroscopy in primary RP 
and FMS
Analyses of categorical data used Chi-square test. Analysis of continuous data used Mann–Whitney U test
RP Raynaud’s phenomenon, FMS fibromyalgia syndrome, IQR interquartile range, CST cold stress test, 
NC nailfold capillaroscopy
Primary RP (n = 85) FMS (n = 43) p value
Age, mean (SD) 47.8 (14.7) 43.8 (10.8) 0.12
Female, n (%) 66 (77.6) 39 (90.7) 0.07
Smoking history, n (%)
 Never 40 (47) 19 (44.2) 0.76
 Ex 31 (36.5) 8 (18.6) 0.04
 Current 14 (16.5) 16 (37.2) 0.009
Diabetes mellitus, n (%) 2 (2.4) 2 (4.7) 0.48
Hypertension, n (%) 16 (18.8) 3 (7.0) 0.08
Hyperlipidaemia, n (%) 11 (12.9) 1 (2.3) 0.05
Vasodilator use, n (%) 21 (24.7) 14 (32.6) 0.35
Questionnaire results
Cold intolerance, n (%) 80 (94.1) 42 (97.7) 0.37
White, n (%) 60 (69.9) 29 (67.4) 0.71
Blue, n (%) 38 (44.7) 14 (32.6) 0.19
Red, n (%) 37 (43.5) 21 (48.8) 0.57
Purple, n (%) 41 (48.2) 16 (37.2) 0.24
Mono-phasic, n (%) 23 (27.1) 14 (32.6) 0.52
Bi-phasic, n (%) 21 (24.7) 11 (25.6) 0.91
Tri-phasic, n (%) 32 (37.6) 13 (30.2) 0.41
Quadriphasic, n (%) 9 (10.6) 5 (11.6) 0.86
Numbness, n (%) 73 (85.9) 41 (95.3) 0.11
Symptoms in absence of cold, n (%) 47 (55.3) 25 (58.1) 0.76
Thumbs involvement, n (%) 31 (36.5) 17 (39.5) 0.74
Toes involvement, n (%) 66 (77.6) 35 (81.4) 0.62
Thermal imaging
Baseline temperature digits, °C (IQR) 29.0 (7.3) 32.1 (7.3) 0.004
Baseline temperature dorsum, °C (IQR) 30.2 (4.4) 31.9 (4.3) 0.005
Baseline thermal gradient, °C (IQR) −0.9 (3.1) 0.0 (3.0) 0.033
Post-CST temperature digits, °C (IQR) 26.5 (7.4) 30.8 (8.6) 0.003
Post-CST temperature dorsum, °C (IQR) 28.8 (4.1) 30.7 (4.6) 0.003
Post-CST thermal gradient, °C (IQR) −2.6 (4.1) −0.2 (3.6) 0.066
Primary RP (n = 48) FMS (n = 18) p value
Nailfold capillaroscopy
Normal nailfold capillaroscopy, n (%) 31 (64.6) 15 (83.3) 0.14
Subtle non-specific NC changes, n (%) 15 (31.3) 3 (16.7) 0.24
Scleroderma-like NC changes, n (%) 2 (4.1) 0 (0) 0.38
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dysfunction and suggest that RP symptoms in FMS may be 
caused by different mechanisms than those seen in primary 
RP or secondary to the autoimmune conditions like SSc.
Our findings were in contrast with earlier smaller stud-
ies, suggesting evidence of microcirculatory dysfunction 
in FMS [6–9, 12]. The present study benefits from being 
comparatively much larger than previous work and from 
having evaluated an enriched cohort of FMS patients spe-
cifically referred for objective assessment of RP symptoms. 
A prospective cross-sectional study of unselected patients 
with FMS would be the preferred method for identifying 
the true burden of RP symptoms in FMS.
The chief limitation of the study was its retrospective 
design, and additional prospective studies are required to 
verify these findings. We relied heavily upon clinician diag-
nosis for disease classification, but this did include assess-
ments such as ANA and trigger point assessments that 
form part of existing classification criteria for primary RP 
Table 2  Relationship between 
reported colour changes 
and baseline thermographic 
assessment
Colour change Thermographic assessment Symptom absent Symptom present p value
Whole cohort
White Digits 31 (8.3) 29.2 (7.5) 0.59
Dorsum 31.1 (4.8) 30.4 (4.2) 0.57
Thermal gradient −0.4 (3.1) −0.6 (3.0) 0.36
Blue Digits 31.7 (7.4) 27.8 (7.0) 0.005
Dorsum 31.4 (4.3) 29.7 (4.7) 0.007
Thermal gradient −0.20 (2.6) −1.8 (3.2) 0.059
Red Digits 30.1 (7.4) 30 (7.8) 0.87
Dorsum 30.4 (4.2) 30.7 (4.7) 0.88
Thermal gradient −0.5 (3.2) −0.7 (2.8) 0.64
Purple Digits 31.4 (6.6) 28.5 (8.0) 0.031
Dorsum 31.3 (3.8) 29.8 (4.9) 0.05
Thermal gradient −0.3 (2.5) −1.1 (3.4) 0.067
Primary Raynaud’s phenomenon
White Digits 31.4 (8.3) 27.9 (7.2) 0.20
Dorsum 31.6 (4.7) 29.8 (4.6) 0.12
Thermal gradient −0.4 (3.4) −1.5 (3.0) 0.38
Blue Digits 30.5 (7.7) 27.4 (8.6) 0.017
Dorsum 31.1 (4.3) 29.5 (5.0) 0.023
Thermal gradient −0.4 (2.8) −2.0 (3.2) 0.133
Red Digits 29.5 (7.4) 27.4 (7.3) 0.52
Dorsum 30.3 (4.3) 29.6 (4.8) 0.48
Thermal gradient −0.6 (3.3) −1.4 (2.8) 0.61
Purple Digits 30.4 (6.8) 27.2 (8.0) 0.13
Dorsum 30.4 (4.0) 29.6 (5.5) 0.20
Thermal gradient −0.4 (2.4) −1.8 (3.3) 0.12
Fibromyalgia syndrome
White Digits 30.8 (8.2) 32.2 (7.4) 0.30
Dorsum 30.6 (5.0) 32.0 (4.2) 0.15
Thermal gradient 0.1 −0.01 (3.3) 0.60
Blue Digits 32.5 (6.4) 30.8 (7.2) 0.22
Dorsum 32.1 (3.8) 31.4 (4.2) 0.31
Thermal gradient 0.02 (2.5) −0.7 (3.7) 0.48
Red Digits 31.4 (7.1) 32.2 (7.5) 0.94
Dorsum 31.4 (4.1) 32.0 (4.3) 0.68
Thermal gradient 0.2 (3.2) −0.02 (2.9) 0.42
Purple Digits 32.3 (6.0) 31.2 (7.9) 0.09
Dorsum 32.1 (3.6) 30.8 (4.1) 0.15
Thermal gradient 0.02 (2.9) −0.01 (3.8) 0.35
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and FMS. It might be argued that the inclusion of patients 
reporting mono-phasic RP and subtle NC changes is not 
compatible with existing classification criteria for primary 
RP [2, 13]. The lower skin temperatures identified in pri-
mary RP patients reporting bi-phasic and tri-phasic RP 
suggests some merit in requiring at least two digital colour 
changes to diagnose RP as has been proposed in classifica-
tion criteria for both RP and systemic sclerosis (SSc) [2, 
14]. In contrast, a higher number of reported digital colour 
changes were associated with higher skin temperatures in 
FMS highlighting a pitfall in this approach. A strength of 
the study was the efforts made to blind assessors to the 
clinical diagnosis when analysing microvascular imaging 
outcomes. Patients with NC changes generally had subtle 
changes that fell short of the NC classification criteria for 
SSc microangiopathy defined by Cutolo et al. [10]. Most 
treating clinicians had regarded the NC appearances as 
within normal limits when considering the images in the 
context of their clinical and serological findings (hence the 
diagnosis of primary RP). Subtle NC changes have been 
identified previously in primary RP, and it has been sug-
gested that primary RP may represent a form fruste of scle-
roderma-spectrum disease [15–17].
This study has implications for existing classifica-
tion criteria of RP-related disorders which heavily rely on 
patient self-report of digital colour changes [2, 13, 14, 18]. 
Digital vasoconstriction in response to cold exposure is an 
important component of healthy thermoregulation, leading 
one early twentieth-century physician to observe “we are 
all subjects of Raynaud’s phenomena to a greater or lesser 
degree” [19]. Our findings suggest that symptoms of RP in 
FMS may have a different aetiology than those seen in pri-
mary RP, which might have implications for the treatment 
of RP symptoms in the context of FMS, where the safety 
and efficacy profiles of vasodilator therapy might differ to 
that demonstrated in previous studies of primary RP.
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